COMPREHENSIVE CANCER CENTRES

Royal Australasian College of SurgeonsAnnual Scientific Congress

Tuesday 4 May 2010

Professor Jim Bishop AO

Chief Medical Officer

Australian Government Department of Health and Ageing

USA COMPREHENSIVE CANCER CENTRES

Initial model- Rosewell Park, Buffalo- Memorial Sloan-Kettering, NY

- MD Anderson, Houston - Fox Chase, Philadelphia

Currently 40 NCI-designated CCC and total of 61 Centres

Cancer Centres Directors Group, NCCN

MILESTONES US CANCER CENTRES PROGRAM

1960 NIH Grant Clinical Research Centres

1961 Cancer Research Facilities Grant

1963 12 Institutions $6m

1968 National Cancer Advisory Board Guidelines

1971 National Cancer Act – Cancer Centres Branch NCI

1973 Cancer Centre Support Grant: Guidelines

1980s Basic, Clinical and Comprehensive Centres

1991 Integration of Research elements

1997 Cancer Centres, Clinical Cancer Centres, Comprehensive Cancer Centres

SIX ESSENTIAL CRITERIA FOR NCI CCC

• Physical facilities dedicated to the conduct of cancer research

• Organisational capability to plan and implement research strategies

• Trans-disciplinary collaboration and co-ordination of research

• Cancer Research Focus

• Institutional Commitment to the Cancer Centre

• Centre Director with Institutional authority to manage the Centre

USA – COMPREHENSIVE CANCER CENTRES

Trans-disciplinary and Translational interaction

Laboratory Research

Clinical Research

Prevention, Control and Population Research

Sources of Cancer Research funding in

NSW (2004-2006)

SOURCE: Cancer Research in NSW 2001-2006Cancer Institute NSW Monograph – March 2008

Sources of Cancer Research funding in NSW

by Survey year

SOURCE: Cancer Research in NSW 2001-2006Cancer Institute NSW Monograph – March 2008

Total funding by broad research area (2004-2006)

SOURCE: Cancer Research in NSW 2001-2006Cancer Institute NSW Monograph – March 2008

Total Funding by geographical hub (2004-

2006)

SOURCE: Cancer Research in NSW 2001-2006Cancer Institute NSW Monograph – March 2008

Geographical Hub

Total funds to hub in survey

period % of total

% Funds to Basic

Research % Funds to

Public Health% Funds to

Clinical research

% Funds to Psycho-social /

behavioural research

Camperdown $32,207,999 24.0% 55.7% 6.6% 27.0% 10.8%

Randwick $26,317,086 19.6% 81.6% 0.9% 13.5% 4.0%

Hunter $20,809,422 15.5% 27.2% 14.4% 43.4% 15.1%

Western Sydney $20,329,413 15.1% 81.0% 2.5% 16.3% 0.2%

Darlinghurst $19,746,918 14.7% 84.3% 2.6% 13.1% 0.0%

Northern Sydney $8,623,733 6.4% 79.5% 0.0% 19.6% 0.9%

Illawarra $2,623,924 2.0% 30.9% 15.5% 37.6% 16.0%

The Cancer Council NSW $1,328,357 1.0% 3.7% 93.5% 2.2% 0.6%

ANSTO $1,113,950 0.8% 81.9% 0.0% 18.1% 0.0%

South Western Sydney $817,329 0.6% 3.4% 55.0% 1.4% 40.2%

Distributed Rural Network $395,733 0.3% 0.0% 5.1% 92.1% 2.8%

CSIRO $150,000 0.1% 100.0% 0.0% 0.0% 0.0%

 Total $134,463,864 100%

Funding within Geographical hubs: proportion

of funds by board research category

SOURCE: Cancer Research in NSW 2001-2006Cancer Institute NSW Monograph – March 2008

The number of publications on cancer for the years 1999-2006 allocated over the eight Australian States according to SCI-SSCI

SOURCE: Cancer Research in NSW 2001-2006Cancer Institute NSW Monograph – March 2008

NHMRC Funding by RESEARCH AREA

2007 2008 2009 2009 ($m) ($m) ($m) %

Laboratory 251 294 346 51%Clinical 152 176 205 30%Public Health 68 79 84 12%Prevention 9 11 14 2%____________________________________________________Totals 500 586 677 100%______________________________________________________________________________

* Additional infrastructure funding not tabulatedNHMRC Strategic Plan 2009

Australian Government Budget 09-10

COAG Agreements $1.1 billion for medical and health

training $872 million for preventative health

NHMRC Funding Increased by 13% to $703m

HHF $1.3 billion for cancer projects * $560 million for regional cancer

centres $1.5 billion for hospital infrastructure

REGIONAL CANCER CENTRE PRINCIPLES

Demonstrated need/impact

Align with Cancer Services

Link to Comprehensive Cancer Care

Provide equitable and affordable access

Address sustainability and workforce

Support Clinical Research Networks

Monitor and evaluate performance

CANCER CARE IN THE FUTURE

Increasing burden of cancer

Research and research information will drive improvement

Integration of research findings into daily practice is everybody’s business

Role delineation, sizing enterprises for function and multidisciplinary research interactions remain a major challenge